PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.790
+0.040 (2.29%)
At close: Oct 2, 2026, 4:00 PM EDT
1.785
-0.005 (-0.28%)
After-hours: Oct 2, 2026, 7:30 PM EDT
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $135.17 million as of October 2, 2026. Its market cap has increased by 87.55% in one year.
Market Cap
135.17M
Enterprise Value
55.95M
1-Year Change
87.55%
Ranking
Category
Stock Price
$1.79
ChartMarket Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $135.17M, a decrease of -91.62%. That is a compound annual growth rate of -33.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 135.17M | 103.22% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Spruce Biosciences | 134.99M |
| enGene Therapeutics | 134.03M |
| Caribou Biosciences | 132.40M |
| Kazia Therapeutics | 129.91M |
| Unicycive Therapeutics | 129.53M |
| Tenaya Therapeutics | 127.81M |
| TuHURA Biosciences | 127.77M |
| Armata Pharmaceuticals | 127.53M |